Nkarta (NASDAQ:NKTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Nkarta (NKTX) operate in?

Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Nkarta Stock (NASDAQ: NKTX) stock price, news, charts, stock research, profile.

Open	$5.91
Close	$5.91
Volume / Avg.	4.01M / 860.40K
Day Range	5.63 - 5.96
52 Wk Range	1.28 - 16.24
Market Cap	$416.46M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	11.27%
Days to Cover	12.49

Recent News

Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing

Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D activities. Acquisition of Clade Therapeutics enhances pipeline with iPSC-focused programs.

Vandana Singh

Nasdaq Turns Higher; Akanda Shares Plunge

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 while the NASDAQ rose 0.06% to 16,439.38. The S&P 500 also fell, dropping, 0.12% to 5,227.95.

Avi Kapoor

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Nkarta Inc

Sector

Health Care

Industry

Biotechnology

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Nkarta (NKTX) stock?

You can purchase shares of Nkarta (NASDAQ:NKTX) through any online brokerage.

View our list of the best stock brokerages

Who are Nkarta (NKTX) competitors?

Other companies in Nkarta’s space includes: Cabaletta Bio (NASDAQ:CABA), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Altimmune (NASDAQ:ALT).

What is the target price for Nkarta (NKTX) stock?

There is no analysis for Nkarta.

What is the forecast for Nkarta (NKTX) stock?

Nkarta has a consensus price target of $20.08.

Current stock price for Nkarta (NKTX)?

The stock price for Nkarta (NASDAQ: NKTX) is $5.91 last updated June 28, 2024 at 4:04 PM EDT.

Does Nkarta (NKTX) pay a dividend?

There are no upcoming dividends for Nkarta.

When is Nkarta (NASDAQ:NKTX) reporting earnings?

Nkarta’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Nkarta (NKTX) going to split?

There is no upcoming split for Nkarta.

What sector and industry does Nkarta (NKTX) operate in?

Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Nkarta

Nkarta (NKTX) Forecast